Dashwood House,
2nd Floor,
69 Old Broad Street,
London,
EC2M 1QS
Direct: +44 (0) 208 588 9100
ADVANZ PHARMA Corp Limited
11-15 Seaton Place
St Helier
Jersey
JE4 0QH
Direct: +44 (0) 208 588 9100
Note: ADVANZ PHARMA is a UK tax resident Company, incorporated in Jersey
+1 855 562 5982
www.advanzpharma.ethicspoint.com
We care about your questions and concerns.
To speak to a customer service executive about any of our products, to check availability of any products, or for any issue related to products or services, please do not hesitate to contact us at the below details.
Our normal opening hours are Monday to Friday GMT 08:30 TO 16:30.
customercare@advanzpharma.com
Direct: +44 (0) 208 588 9441
Austria +43 (0) 800 298 022
Australia: +612 9431 6333
Belgium: +32 (0)800 78 941
Canada: + 1 800 982-0340
Denmark: +45 80 82 60 22
Finland: +358 800 416231
France: +33 1 77 68 89 17 (Correvio)
France: +33 176 701 049 (ADVANZ PHARMA France)
Germany +49 (0)800 1802 091
Ireland: +353 1800 851 119
Italy: +39 800 909 792
Netherlands: +31 (0)800 022 93 82
New Zealand: +64 (0) 800 565 633
Norway: +47 800 16 689
Portugal: +351 800 819 926
Spain +34 900 834889
Sweden: +46 840 838 440
Switzerland: +41 (0)848 007 970
UK: +44 (0) 208 588 9131
USA: +1 877 370 1142
International: +44 (0) 208 588 9131
medicalinformation@advanzpharma.com
drugsafety@advanzpharma.com
Canada
medicalinformation.ca@advanzpharma.com
Medical Information Website
medicalinformation.advanzpharma.com
For press/media enquiries, please
email: mediaenquiries@advanzpharma.com
Business Development
Customer Care - International
Customer Care - IE
General Enquiries
Investors
Product Enquiry – Medical Information/Safety
Product Enquiry – Quality/Complaint
Product Supply Enquiry - International
Product Supply Enquiry - UK
Product Supply Enquiry - IE
Press Enquiry
Regulatory Enquiry
The following entities are all trading divisions of ADVANZ PHARMA Corp.
Mercury Pharmaceuticals Ltd
Amdipharm Ltd
Focus Pharmaceuticals Ltd
Advanz Pharma Generics (UK) Ltd
Advanz Pharma Services (UK) Ltd
Abcur AB
BNM (Boucher & Muir PTY Limited – Australia)
Pinnacle
Direct: +44 (0) 208 588 9100
Direct: +612 9431 6333
ADVANZ PHARMA CANADA Inc.
4263 Sherwoodtowne Blvd., Suite 300 Mississauga, ON L4Z 1Y5
Our Products
Tel. : +33 (0)1 77 68 89 17
Fax: +33 (0)1 85 78 76 43
www.advanzpharma.com
enquiries@advanzpharma.com
Rosenheimer Str. 52 81669 München +49 89 4111 124 11
Herforder Str. 69, 33602 Bielefeld
Direct: +91 22 6678 4444
Fax: +91 22 6677 1262
Direct: +353 (0)1 6971640
Fax: +353 (0)1 6971642
Commercial / Customer Support +353 1 5294230
Direct: +4642 135 770
Fax: +4642 135 771
General queries: enquiries@advanzpharma.com
Product queries: medicalinformation@advanzpharma.com
tel: +41 (0) 84 800 79 70
fax: +41 (0) 22 907 79 71
Phone: +1 877 370 1142
PINNACLE BIOLOGICS
The following entities are all trading divisions of ADVANZ PHARMA Corp.
Mercury Pharmaceuticals Ltd
Amdipharm Ltd
Focus Pharmaceuticals Ltd
Advanz Pharma Generics (UK) Ltd
Advanz Pharma Services (UK) Ltd
Abcur AB
BNM (Boucher & Muir PTY Limited – Australia)
Pinnacle
Direct: +44 (0) 208 588 9100
Direct: +612 9431 6333
ADVANZ PHARMA CANADA Inc.
4263 Sherwoodtowne Blvd., Suite 300 Mississauga, ON L4Z 1Y5
Our Products
Tel. : +33 (0)1 77 68 89 17
Fax: +33 (0)1 85 78 76 43
www.advanzpharma.com
enquiries@advanzpharma.com
Rosenheimer Str. 52 81669 München +49 89 4111 124 11
Herforder Str. 69, 33602 Bielefeld
Direct: +91 22 6678 4444
Fax: +91 22 6677 1262
Direct: +353 (0)1 6971640
Fax: +353 (0)1 6971642
Commercial / Customer Support +353 1 5294230
Direct: +4642 135 770
Fax: +4642 135 771
General queries: enquiries@advanzpharma.com
Product queries: medicalinformation@advanzpharma.com
tel: +41 (0) 84 800 79 70
fax: +41 (0) 22 907 79 71
Phone: +1 877 370 1142
PINNACLE BIOLOGICS
Are you looking for a job with us? Please visit our Careers section.
INFORMATION REGARDING FORMAL SALE PROCESS
ACCESS TO THIS AREA OF THE WEBSITE MAY BE RESTRICTED UNDER SECURITIES LAWS IN CERTAIN JURISDICTIONS. THIS NOTICE REQUIRES YOU TO CONFIRM CERTAIN MATTERS (INCLUDING THAT YOU ARE NOT RESIDENT IN SUCH A JURISDICTION), BEFORE YOU MAY OBTAIN ACCESS TO THE INFORMATION IN THIS AREA OF THE WEBSITE. THESE MATERIALS ARE NOT DIRECTED AT OR TO BE ACCESSED BY PERSONS RESIDENT IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION OR WOULD RESULT IN A REQUIREMENT TO COMPLY WITH ANY CONSENT OR OTHER FORMALITY WHICH ADVANZ PHARMA CORP. LIMITED REGARDS AS UNDULY ONEROUS.
You are attempting to enter the area of this website that is designated for the publication of documents and information in connection with ADVANZ PHARMA Corp. Limited (“ADVANZ”) formal sale process.
The information contained in this area of this website is being made available in good faith and for information purposes only in compliance with the City Code on Takeovers and Mergers and is subject to the terms and conditions set out below. In particular, the information contained in this area of this website does not constitute an offer to sell or otherwise dispose of or any invitation or solicitation of any offer to purchase or subscribe for any securities in any jurisdiction in which such offer or solicitation is unlawful.
Access to the Website
If you would like to view this area of the website, please read this notice carefully. This notice applies to all persons who view this area of the website and, depending on where you are located, may affect your rights or responsibilities. ADVANZ reserves the right to amend or update this notice at any time and you should, therefore, read it in full each time you visit this area of the website. In addition, the contents of this area of the website may be amended at any time in whole or in part at the sole discretion of ADVANZ.
Overseas Persons
As a consequence of legal restrictions, the release, publication or distribution of information contained in this area of the website in certain jurisdictions or to certain persons may be restricted or unlawful. All persons resident or located outside the United Kingdom who wish to view this area of the website must first satisfy themselves that they are not subject to any local requirements that prohibit or restrict them from doing so and should inform themselves of, and observe, any applicable legal or regulatory requirements applicable in their jurisdiction. If you are resident or located in a country that renders the accessing of this area of the website or parts thereof illegal, whether or not subject to making certain notifications or taking other action, you should not view this area of the website.
It is your responsibility to satisfy yourself as to the full observance of any relevant laws and regulatory requirements. If you are in any doubt, you should not continue to seek to access this area of the website.
You should not forward, transmit or show the announcements, information or documents contained in this area of the website to any person. In particular, you should not forward or transmit the announcements, information or documents contained in this area of the website to any jurisdiction where it would be unlawful to do so.
Forward Looking Statements
This area of the website contains “forward-looking statements”. These statements are based on the current expectations of the management of ADVANZ and are naturally subject to uncertainty and changes in circumstances.
Forward-looking statements include, without limitation, statements typically containing words such as “intend”, “expect”, “anticipate”, “target”, “estimate”, “plan”, “strategy”, “will”, “should”, “may”, “goal”, “seek”, “believe”, “predict”, “continue”, “future”, “could”, “can” and words of similar import. These forward looking statements are not guarantees of future performance. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied by such forward-looking statements. These factors include, but are not limited to, changes in economic conditions, changes in the level of capital investment, success of business and operating initiatives and restructuring objectives, costs associated with research and development, changes in the prospects for products in the research and development pipeline of ADVANZ, customers’ strategies and stability, changes in the regulatory environment, fluctuations of interest and exchange rates, the outcome of litigation, government actions and natural phenomena such as floods, earthquakes and hurricanes. Other unknown or unpredictable factors could cause actual results to differ materially from those in the forward-looking statements. ADVANZ does not undertake any obligation to update publicly or revise forward-looking statements, whether as a result of new information, future events or otherwise, except to the extent legally required.
Given these risks and uncertainties, investors should not place undue reliance on forward-looking statements as a prediction of actual results. Neither ADVANZ nor any of its affiliated companies undertakes any obligation to update or revise forward-looking statements, whether as a result of new information, future events or otherwise, except to the extent legally required.
Responsibility
In relation to any document, announcement or information contained in this area of the website, the only responsibility accepted by the directors of ADVANZ (the “Responsible Persons”) is for the correctness and fairness of its reproduction or presentation, unless the responsibility statement in any relevant document expressly provides otherwise.
None of the Responsible Persons, ADVANZ or its affiliated companies have reviewed and none of them is responsible for, or accepts any liability in respect of, any information on any other website that may be linked to this website by a third party.
The documents included in this area of the website speak only at the specified date of the relevant document and neither ADVANZ nor any of its affiliated companies has or accepts any responsibility or duty to update such documents (other than to the extent such duty arises as a matter of law).
If you are in any doubt about the contents of this area of the website or the action you should take, you should seek your own financial advice from an independent financial adviser authorised under the Financial Services and Markets Act 2000 or, if you are located outside the United Kingdom, from an appropriately authorised independent financial adviser.
THE DOCUMENTS IN THIS AREA OF THE WEBSITE MAY NOT BE DOWNLOADED, FORWARDED, TRANSMITTED OR SHARED WITH ANY OTHER PERSON EITHER IN WHOLE OR IN PART WHERE TO DO SO WOULD OR MAY CONSTITUTE A BREACH OF ANY APPLICABLE LOCAL LAWS OR REGULATIONS.
Electronic versions of these materials are not directed at or accessible by persons resident in any jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction.
This notice shall be governed by, and interpreted in accordance with, English law.
Confirmation of Understanding and Acceptance of Disclaimer. If you do not click “I AGREE” below you will not be permitted access to this area of the website.